GlobeNewswire (press release)Intrommune Therapeutics Submits Pre-IND Meeting Request to the US FDA for INT301, Its Peanut Allergy Oral Mucosal …GlobeNewswire (press release)New York, May 15, 2018 (GLOBE NEWSWIRE) –. Intrommune Therapeutics, a NYC-ba… Continue reading
Immunotherapy Offers Survival and Quality-of-Life Benefits in Head and Neck CancerCuretoday.com“For a group of patients who have very poor prognosis, it was the first study to demonstrate that immunotherapy was clinically effective and better than the … Continue reading
Baylor College of Medicine News (press release) (blog)FROM THE LABS: Special delivery of IL-7 signaling makes all the difference for CAR T cells fighting solid tumorsBaylor College of Medicine News (press release) (blog)Shum became particularly interes… Continue reading
Singularity Hub |
Scientists Kick Off Synthetic Biology Project to Make Virus-Resistant Super Cells
Singularity Hub Their agenda? Creating “superhero” human cells impervious to all viral attacks and possibly other killers—radiation, freezing, aging, or even cancer. The trick isn’t super-soldier serum. Instead, the team is relying on tools from synthetic biology to … |
Singularity Hub |
Scientists Kick Off Synthetic Biology Project to Make Virus-Resistant Super Cells
Singularity Hub Their agenda? Creating “superhero” human cells impervious to all viral attacks and possibly other killers—radiation, freezing, aging, or even cancer. The trick isn’t super-soldier serum. Instead, the team is relying on tools from synthetic biology to … |
FiercePharma |
Gilead to build its EU CAR–T manufacturing facility at Amsterdam airport
FiercePharma Speed is of the essence when it comes to manufacturing CAR T drugs—personalized treatments in which immune cells are engineered to recognize and destroy patients’ cancers. With that in mind, Gilead will locate a new European manufacturing site for its … Kite expands manufacturing capacity for CAR–T therapiespharmaphorum |